125 related articles for article (PubMed ID: 25941336)
1. RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression.
Esposito M; Kang Y
Cancer Discov; 2015 May; 5(5):466-8. PubMed ID: 25941336
[TBL] [Abstract][Full Text] [Related]
2. Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic Acid-induced 2.
Werner S; Brors B; Eick J; Marques E; Pogenberg V; Parret A; Kemming D; Wood AW; Edgren H; Neubauer H; Streichert T; Riethdorf S; Bedi U; Baccelli I; Jücker M; Eils R; Fehm T; Trumpp A; Johnsen SA; Klefström J; Wilmanns M; Müller V; Pantel K; Wikman H
Cancer Discov; 2015 May; 5(5):506-19. PubMed ID: 25716347
[TBL] [Abstract][Full Text] [Related]
3. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score.
Hartkopf AD; Wallwiener M; Kommoss S; Taran FA; Brucker SY
Breast Cancer Res Treat; 2016 Feb; 156(1):91-5. PubMed ID: 26911294
[TBL] [Abstract][Full Text] [Related]
4. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
5. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
6. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
[TBL] [Abstract][Full Text] [Related]
7. Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.
Schindlbeck C; Andergassen U; Jueckstock J; Rack B; Janni W; Jeschke U
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1883-95. PubMed ID: 26825607
[TBL] [Abstract][Full Text] [Related]
8. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
[TBL] [Abstract][Full Text] [Related]
9. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.
Sänger N; Effenberger KE; Riethdorf S; Van Haasteren V; Gauwerky J; Wiegratz I; Strebhardt K; Kaufmann M; Pantel K
Int J Cancer; 2011 Nov; 129(10):2522-6. PubMed ID: 21207426
[TBL] [Abstract][Full Text] [Related]
10. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
Lang JE; Hall CS; Singh B; Lucci A
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
[TBL] [Abstract][Full Text] [Related]
11. A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
Fratamico RS; Strickland KS; Uppal G; Abu-Khalaf M
Clin Breast Cancer; 2018 Jun; 18(3):e295-e298. PubMed ID: 28735676
[No Abstract] [Full Text] [Related]
12. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
13. Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Rack B; Zombirt E; Trapp E; Jückstock J; Andergassen U; Neugebauer J; Kost B; Weissenbacher T; Jeschke U; Schindlbeck C; Janni W; Alunni-Fabbroni M
Oncology; 2016; 90(4):232-8. PubMed ID: 26937631
[TBL] [Abstract][Full Text] [Related]
14. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.
Janni W; Vogl FD; Wiedswang G; Synnestvedt M; Fehm T; Jückstock J; Borgen E; Rack B; Braun S; Sommer H; Solomayer E; Pantel K; Nesland J; Friese K; Naume B
Clin Cancer Res; 2011 May; 17(9):2967-76. PubMed ID: 21415211
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
17. Low RAI2 expression is a marker of poor prognosis in breast cancer.
Nishikawa S; Uemoto Y; Kim TS; Hisada T; Kondo N; Wanifuchi-Endo Y; Fujita T; Asano T; Katagiri Y; Terada M; Kato A; Dong Y; Sugiura H; Okuda K; Kato H; Osaga S; Takahashi S; Toyama T
Breast Cancer Res Treat; 2021 May; 187(1):81-93. PubMed ID: 33782811
[TBL] [Abstract][Full Text] [Related]
18. Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development.
Pillai SG; Dasgupta N; Siddappa CM; Watson MA; Fleming T; Trinkaus K; Aft R
Breast Cancer Res Treat; 2015 Oct; 153(3):507-17. PubMed ID: 26400846
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
20. Detection and management of bone marrow micrometastases in breast cancer.
Osborne MP; Rosen PP
Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]